Advertisement
Journal Home
Search for

Volume 67, Issue 1, Pages 67-70 (January 2003)


View previous. 5 of 22 View next.

Bilateral cochlear implantation in children

Katrien VermeireaCorresponding Author Informationemail address, Jan P.L. Brokxab, Paul H. Van de Heyninga, Ellen Cocheta, Hilde Carpentiera

Received 5 February 2002; received in revised form 13 August 2002; accepted 14 August 2002.

Abstract 

Aims: to determine the benefit of bilateral cochlear implantation in a child on speech and language development. Method: This child got her first implant, a Nucleus 24-system, on the right side at the age of 2.5 years. The left side was implanted at the age of 4.4 years with a Nucleus 24Contour-system. On the right side she's now wearing an Esprit 24-speechprocessor (SPR). On the left side she has a Sprint-SPR. M. goes to a mainstream school and receives Speech and Language therapy in a Speech and Hearing Rehab Centre. The etiology of her deafness was hyperbilirubinemia. Auditory capacity and speech recognition tests were performed for both ears separately and together. Results: Aided thresholds give a PTA of 28 dBA with the first implant, 22 dBA with the second implant and with both implants we get a PTA of 23 dBA. Results for speech identification and recognition demonstrated an increased performance when both implants are used together. Speech and language development was equivalent to the mean of age 4.5. At the time of testing M. was 4.8 years. At this time the speech and language development show no delays with normal hearing children. Conclusions: bilateral cochlear implantation in children may have additional value for their speech and language development. Also, implantation may be considered when auditory neuropathy is likely.

a Department of Otorhinolaryngology & Communication Disorders, University of Antwerp, Wilrijkstraat 10, 2650 Antwerp (Edegem), Belgium

b Department of Audiology, Institute for the Deaf, Sint-Michielsgestel, 's Hertogenbosch, Netherlands

Corresponding Author InformationCorresponding author. Tel.: +32-38-213-442; fax: +32-38-250-536

PII: S0165-5876(02)00286-0


View previous. 5 of 22 View next.

Advertisement